Accepted Manuscript Pulmonary thromboembolism after carbon monoxide poisoning: A case series and review of the literature
Yoonje Lee, Tae Ho Lim, Hyunggoo Kang, Jaehoon Oh, Byuk Sung Ko PII: DOI: Reference:
S0735-6757(18)30443-1 doi:10.1016/j.ajem.2018.05.063 YAJEM 57565
To appear in:
American Journal of Emergency Medicine
Received date: Accepted date:
23 May 2018 29 May 2018
Please cite this article as: Yoonje Lee, Tae Ho Lim, Hyunggoo Kang, Jaehoon Oh, Byuk Sung Ko , Pulmonary thromboembolism after carbon monoxide poisoning: A case series and review of the literature. Yajem (2017), doi:10.1016/j.ajem.2018.05.063
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
Case report Pulmonary thromboembolism after carbon monoxide poisoning: A case series and review of the literature Short running title: Pulmonary thromboembolism with carbon monoxide
PT
Yoonje Lee, MD; Tae Ho Lim, MD, PhD; Hyunggoo Kang, MD, PhD; Jaehoon Oh, MD, PhD; Byuk
RI
Sung Ko, MD, PhD
NU
SC
Department of Emergency Medicine, College of Medicine, Hanyang University, Seoul, Korea.
CORRESPONDENCE TO: Byuk Sung Ko, MD, PhD
PT E
E-mail:
[email protected]
D
Seongdong-gu, Seoul 133-791, Korea
MA
Department of Emergency Medicine, College of Medicine, Hanyang University, 222 Wangsimni-ro
Author contributions: YL and BSK wrote the article. YL and BSK conceived the idea. HK and JO
CE
collected data. THL and HK conducted a critical review and supervised the whole study process. Ethics approval and consent to participate: The institutional review board of each institution
AC
approved the study and waived informed consent. Competing interests: The authors declare that they have no competing interests. Funding: This study was not financed. Acknowledgements: No acknowledgements to declare. Data availability statement: The data that support the findings of this study are available on request from the corresponding author, BS Ko. The data are not publicly available due to restrictions their containing information that could compromise the privacy of research participants.
ACCEPTED MANUSCRIPT
ABBREVIATIONS LIST CO = carbon monoxide; CPC = cerebral performance category; DVT = deep vein thrombosis; HBOT = hyperbaric oxygen treatment; LMWH = low-molecular-weight heparin; NOAC = new oral
AC
CE
PT E
D
MA
NU
SC
RI
PT
anticoagulant; PTE = pulmonary thromboembolism; CO hemoglobin = COHb
ACCEPTED MANUSCRIPT
ABSTRACT Objective: Carbon monoxide (CO) poisoning is known to increase thrombotic tendency, and the risk of deep vein thrombosis in individuals who have experienced CO poisoning is higher than in the
PT
general population. However, there are a few reports describing cases of pulmonary
RI
thromboembolisms (PTE) secondary to CO poisoning.
SC
Data Sources: Retrospective data analysis.
NU
Study Selection: Seven hundred fifty bed tertiary university affiliated hospital. Data Extraction and synthesis: Five patients with PTE after CO poisoning were observed. Two
MA
patients experienced cardiac arrest; they were treated successfully with tissue plasminogen activators and targeted temperature management. Their cerebral performance scores at discharge were both 1.
D
Three patients had PTE and were treated with anticoagulation.
PT E
Conclusions: To date, the causal relationship between PTE and CO poisoning is unclear. However, PTE should be considered in patients with CO poisoning as a differential diagnosis when unexplained
AC
are warranted.
CE
hypoxemia or shock are observed. Further studies on the association between CO poisoning and PTE
Key Words: carbon monoxide poisoning; pulmonary thromboembolism
ACCEPTED MANUSCRIPT
Introduction Carbon monoxide (CO) poisoning has been associated with thrombotic tendency; previous reports have described thrombosis in various organs.1-3 Cerebral, cardiac, mesenteric, and deep vein
PT
thrombosis (DVT) are associated with CO poisoning.4 One nationwide cohort study demonstrated that the risk of DVT is significantly higher in patients with CO poisoning.5 However, the association
RI
between CO poisoning and pulmonary thromboembolism (PTE) was not clear in that study.
SC
Furthermore, few reports about PTE exist to date. We present 5 cases of PTE in patients treated for
NU
CO poisoning.
MA
CASE 1
A 23-year-old woman was transferred from another hospital for CO poisoning. She had attempted to
D
commit suicide by ingesting burning charcoal with alcohol. She had major depressive disorder and
PT E
obesity. She responded to verbal commands. Her initial systolic blood pressure, diastolic blood pressure were 122 mmHg and 83 mmHg, respectively (Table 1). Her CO hemoglobin (COHb) level at
CE
first visited hospital could not be obtained. Her COHb level in our hospital was 2.9%. She was admitted to the general ward and was planned to receive hyperbaric oxygen treatment (HBOT).
AC
Eighteen hours after admission, she was collapsed in toilet and cardiac arrest occurred. Echocardiography showed a D-shaped left ventricle and dilatation of the right ventricle (Figure 1). She was successfully treated with intravenous tissue plasminogen activators and targeted temperature treatment. A PTE in the right pulmonary artery was observed using computed tomography (CT) (Figure 2). Low-molecular-weight heparin (LMWH) was administered and it was switched to new oral anticoagulants (NOAC). Her cerebral performance category (CPC) score at discharge was 1. CASE 2
ACCEPTED MANUSCRIPT
A 52-year-old woman was transferred from another hospital for intentional CO poisoning with charcoal burning and drugs. She did not have any chronic disease. Her COHb level at first visited hospital was 23.1% (Table 1). Her COHb level in our hospital was 7.9%. She was admitted to the general ward and received 3 courses of HBOT in 2.5 atmospheres absolute. Sixty-two hours after admission, cardiac arrest occurred. Right ventricle dilation and pulmonary hypertension on
PT
echocardiography was observed (Figure 3). A PTE in the left inferior pulmonary artery was observed
RI
using CT (Figure 4). The same treatment as that administered in case 1 was administered and her CPC
SC
score at discharge was 1. CASE 3
NU
A 48-year-old man was transferred from another hospital for intentional CO poisoning with charcoal burning and drugs. He did not have any comorbidities. His COHb level at first visited hospital was
MA
50.0% (Table 1). His COHb level in our hospital was 8.6%. He was admitted to the general ward and was planned to receive HBOT. Ten hours after admission, he had dyspnea and hypoxemia. His d-
D
dimer levels were 1.32 mg/L and cardiac enzyme levels were also elevated (Table 1). PTE in the right
PT E
upper and middle lobar arteries were observed using CT. Echocardiography did not show evidence of
CASE 4
CE
pulmonary hypertension. LMWH and NOAC were administered and his hypoxemia improved.
AC
A 63-year-old man was accidentally exposed to burning charcoal gas and intubated for comatose mentality. He had no chronic disease. His COHb level at first visited hospital was 6.8% (Table 1). His COHb level in our hospital was 0.9%. He had fever and elevated C-reactive protein levels, and chest CT was conducted to identify aspiration pneumonia. PTE in both pulmonary arteries were observed on chest CT incidentally. He could not complain of dyspnea or chest discomfort because of decreased mentality. No hypoxemia was observed. Echocardiography did not show evidence of pulmonary hypertension. LMWH and NOAC were administered and the extent of the PTE decreased on followup CT.
ACCEPTED MANUSCRIPT
CASE 5 A 46-year-old woman was transferred from another hospital for intentional CO poisoning with charcoal burning. She had major depressive disorder. Her COHb level at first visited hospital was 9.0% (Table 1). Her COHb level in our hospital was 1.6%. Twelve hours after admission, she had
PT
hypoxemia and tachypnea. Her d-dimer levels were 3.20 mg/L and tropoin I levels was 3.698 ng/mL (Table 1). PTE in the both interlobar arteries were observed using CT. Echocardiography did not show
RI
evidence of pulmonary hypertension. LMWH and NOAC were administered and her hypoxemia
SC
improved.
NU
DISCUSSION
To the best of our knowledge, this case series is the first describing PTE associated with CO
MA
poisoning. The patients in our study (except for 1 obese patient) had none of the conditions commonly associated with PTE, including recent surgery, trauma, active cancer, hormone therapy,
D
immobilization, or heavy smoking. Episodes of PTE might be secondary to CO poisoning and
PT E
massive PTE; even cardiac arrest can be observed in patients with CO poisoning. CO poisoning is known to be associated with more cardiovascular morbidity and mortality than in control populations based on epidemiology studies.6,7 The main mechanisms of cardiovascular disease
CE
by CO poisoning are hypoxia and atherosclerosis.8 Accumulation of cholesterol in the coronary artery
AC
and endothelial damage was shown in several animal studies.9,10 CO poisoning is also known to cause inflammation and hypoxia, which could induce endothelial injury and hypercoagulability.5 With respect to venous thrombosis, CO has been found to induce thrombus formation through bloodstream stasis, increasing vascular permeability, leading to platelet dysfunction and polycythemia.1 Chung et. al. demonstrated that CO poisoning was associated with a 3.85-fold higher risk of DVT than in a control group without CO poisoning.5 However, the association with PTE was not significant after adjusting for confounding variables. They explained that CO causes hypoxia and inflammation by increasing levels of oxygenase-1 protein, and releasing myeloperoxidase and
ACCEPTED MANUSCRIPT
reactive oxygen species, which lead to oxidative stress. Venous thrombosis has been reported to be associated with inflammation and oxidative stress. One 22-year-old man was treated for CO poisoning and DVT was detected.11 One PTE with CO poisoning has been reported in a 70-year-old man.12 To date, we could not find reports of massive embolisms, which even result in cardiac arrest.
PT
Physicians should consider PTE and DVT as differential diagnoses when there are unexplained dyspnea, hypoxemia, or shock in patients with CO poisoning. However, the association between CO
AC
CE
PT E
D
MA
NU
SC
RI
poisoning and PTE remains unclear; hence, further investigation is warranted.
PT
ACCEPTED MANUSCRIPT
1.
RI
References
Grace TW, Platt FW. Subacute carbon monoxide poisoning. Another great imitator. JAMA.
2.
SC
1981;246(15):1698-1700.
Nielsen VG, Hafner DT, Steinbrenner EB. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide. Blood Coagul Fibrinolysis. 2013;24(4):405-410. Aronow WS.
Effect
of
carbon
monoxide on
1979;8(3):271-278. 4.
NU
3.
cardiovascular
Prev Med.
disease.
Teodoro T, Geraldes R, Pinho e Melo T. Symptomatic internal carotid artery thrombosis in
5.
MA
acute carbon monoxide intoxication. Am J Emerg Med. 2014;32(6):684 e685-686. Chung WS, Lin CL, Kao CH. Carbon monoxide poisoning and risk of deep vein thrombosis and pulmonary embolism: a nationwide retrospective cohort study. J Epidemiol Koskela RS. Cardiovascular diseases among foundry workers exposed to carbon monoxide.
PT E
6.
D
Community Health. 2015;69(6):557-562. Scand J Work Environ Health. 1994;20(4):286-293. 7.
Stern FB, Lemen RA, Curtis RA. Exposure of motor vehicle examiners to carbon monoxide: a historical prospective mortality study. Arch Environ Health. 1981;36(2):59-65. Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL. Cardiovascular effects of carbon
CE
8.
monoxide and cigarette smoking. J Am Coll Cardiol. 2001;38(6):1633-1638. 9.
Astrup P, Kjeldsen K, Wanstrup J. Effects of carbon monoxide exposure on the arterial walls.
10.
AC
Ann N Y Acad Sci. 1970;174(1):294-300. Chen YG, Lin TY, Dai MS, et al. Risk of Peripheral Artery Disease in Patients With Carbon Monoxide Poisoning: A Population-Based Retrospective Cohort Study. Medicine (Baltimore). 2015;94(40):e1608. 11.
De Matteis G, Fuorlo M, Montalto M, Landolfi R. Screening for and prophylaxis of venous thromboembolism
in
severe
carbon
monoxide
poisoning?
Am
J
Emerg
Med.
2015;33(4):592-593. 12.
Sevinc A, Savli H, Atmaca H. An interesting cause of pulmonary emboli: acute carbon monoxide poisoning. Clin Appl Thromb Hemost. 2005;11(3):353-357.
PT
ACCEPTED MANUSCRIPT
RI
Figure Legends
Fig. 1 Echocardiography in case 1. Echocardiography shows D-shaped LV and right ventricle
SC
dilatation. LV, left ventricle.
MA
pulmonary artery. CT, computed tomography.
NU
Fig. 2 Pulmonary embolism CT in case 1. A pulmonary thromboembolism is observed in the right
Fig. 3 Echocardiography in case 2. Right ventricle dilation and pulmonary hypertension is observed.
D
Fig. 4 Pulmonary embolism CT in case 2. A pulmonary thromboembolism is observed in the left
AC
CE
PT E
inferior pulmonary artery. CT, computed tomography.럏
ACCEPTED MANUSCRIPT
TABLE 1. Patient Characteristics
Characteristics
Patient No.
2
3
4
5
Age (years)
23
52
48
63
46
Sex
Female
Female
Male
Comorbidities
MDD, obesity
None
None
Cigarette-
No
No
Yes
Yes
Yes
Yes
RI
No
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
No
SC
No
NU
No
D
Normobaric
Female
MDD
MA
another hospital
Male
None
smoking
Transferred from
PT
1
Propranolol,
administered
Zanapam
Initial vital signs
AC
Medication
CE
PT E
oxygen applied
SBP (mmHg)
122
101
143
119
106
DBP (mmHg)
83
54
78
86
70
HR (beats/min)
92
75
100
84
86
RR (breaths/min)
18
20
20
24
18
BT (°C)
36.5
34.8
36.8
38.1
36.5
ACCEPTED MANUSCRIPT
Blood oxygen
100
99
100
100
99
Verbal
Painful
Alert
Unresponsive
Verbal
Not checked
23.1
50.0
13,100
6,000
13,700
14.0
11.5
216,000
235,000
saturation (%)
Mental status
Laboratory
19,100
16.0
10.0
14.4
226,000
133,000
333,000
D
(g/dL)
Platelet
9.0
8,300
NU
Hemoglobin
MA
(counts/mm3)
SC
hemoglobin (%)
WBC
6.8
RI
Initial CO
PT
findings
PT E
(counts/mm3)
1.87
0.24
1.32
6.86
3.20
CK (U/L)
363
86
8257
5994
31649
4.3
0.9
43.6
6.2
300
0.279
0.01
2.398
0.076
3.698
93
16
80
81
315
24
62
10
48
12
(ng/mL)
AC
CK-MB
CE
D-dimer (mg/L)
Troponin-I (ng/mL)
BNP (pg/mL)
Other features
CO exposure to
ACCEPTED MANUSCRIPT
PTE (h)
PTE before
No
Yes, 3 times
No
No
Yes
Cardiac arrest
Yes
Yes
No
no
No
Treatment
tPA
tPA
Anticoagulation
Anticoagulation
Anticoagulation
Anticoagulation
Anticoagulation
TTM
TTM
No test
No DVT
RI SC
DVT
No test
Right upper
Both pulmonary
Both interlobar
middle lobe
artery
artery
Sinus rhythm
Sinus rhythm
pulmonary
pulmonary
artery
artery
lobar artery
Sinus
Sinus rhythm
Sinus
MA
Left inferior
PT E
tachycardia
tachycardia
Pulmonary
Pulmonary
No pulmonary
No pulmonary
No pulmonary
hypertension
hypertension
hypertension
hypertension
hypertension
CE
Echocardiography
No test
Right
D
ECG
Lt. tibial vein
NU
(after tPA)
Site of PTE
PT
HBOT
AC
BNP = B-type natriuretic peptide; BT = body temperature; CK = creatine kinase; CK-MB = creatine kinase-muscle/brain; CO = carbon monoxide; DBP = diastolic blood pressure; DVT = deep vein thrombosis; ECG = electrocardiogram; HBOT = hyperbaric oxygen treatment; HR = heart rate; MDD = major depressive disorder; PTE = pulmonary thromboembolism; RR = respiratory rate; SBP =
systolic blood pressure; tPA = tissue plasminogen activator; TTM = targeted temperature management.
Figure 1
Figure 2
Figure 3
Figure 4